These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6356854)

  • 1. Double-blind comparison of trimazosin and propranolol in essential hypertension.
    Helgeland A
    Am Heart J; 1983 Nov; 106(5 Pt 2):1253-8. PubMed ID: 6356854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide.
    Moyer RR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1250-3. PubMed ID: 6356853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac muscle mass during vasodilation therapy of hypertension.
    Drayer JI; Gardin JM; Weber MA; Aronow WS
    Clin Pharmacol Ther; 1983 Jun; 33(6):727-32. PubMed ID: 6221856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vasodilator that avoids renin stimulation and fluid retention: antihypertensive treatment with trimazosin.
    Weber MA; Brewer DD; Drayer JI; Aronow WS; Lipson JL; Ricci BA
    Clin Pharmacol Ther; 1982 May; 31(5):572-8. PubMed ID: 7042174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension.
    Webb DJ; Hutcheson MJ; Robertson MP; Murray GD; Lorimer AR; Robertson JI
    Scott Med J; 1985 Apr; 30(2):106-10. PubMed ID: 3892676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of trimazosin: an effective and safe antihypertensive agent.
    Taylor CR; Leader JP; Singleton W; Munster EW; Falkner FC; O'Neil JA
    Am Heart J; 1983 Nov; 106(5 Pt 2):1269-81. PubMed ID: 6227228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of propranolol and prazosin upon serum lipids in thiazide- treated hypertensive patients.
    Johnson BF; Romero L; Johnson J; Marwaha R
    Am J Med; 1984 Feb; 76(2A):109-12. PubMed ID: 6367445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a sustained-release formulation of trimazosin in mild to moderate hypertension.
    Byyny RL; Nies AS; LoVerde ME; Mitchell WD
    J Clin Pharmacol; 1987 Feb; 27(2):101-5. PubMed ID: 3680560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
    Chrysant SG
    Am Heart J; 1983 Nov; 106(5 Pt 2):1243-50. PubMed ID: 6356852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between clinic and ambulatory blood pressure measurement in the evaluation of two antihypertensive agents.
    O'Brien E; Cox JP; Fitzgerald DJ; O'Malley K
    J Hum Hypertens; 1989 Aug; 3(4):259-62. PubMed ID: 2677376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
    Misson R; Merkel T; Cutler RE
    Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension with a combination of prazosin and polythiazide.
    Oh MS; Carroll HJ; Cruz WM; Whang ES; Lejano RF
    Postgrad Med; 1975 Nov; Spec No():77-80. PubMed ID: 1105488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical hemodynamic profile of trimazosin in hypertension.
    Pool PE; Seagren SC; Salel AF
    Am Heart J; 1983 Nov; 106(5 Pt 2):1237-42. PubMed ID: 6356851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
    Lowenstein J; Neusy AJ
    Am J Med; 1984 Feb; 76(2A):79-84. PubMed ID: 6702864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
    Nelson GI; Silke B; Hussain M; Verma SP; Taylor SH
    Am Heart J; 1984 Jul; 108(1):124-31. PubMed ID: 6731261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of an additive antihypertensive effect of prazosin and polythiazide in out-patient.
    Kuokkanen K; Mattila MJ
    Curr Ther Res Clin Exp; 1975 May; 17(5):431-6. PubMed ID: 805026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.